Try our Advanced Search for more refined results
KING DRUG COMPANY OF FLORENCE, INC vs. CEPHALON, INC., ET AL
Case Number:
2:06-cv-01797
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Akin Gump
- Armstrong Teasdale
- Berger Montague
- Clark Hill
- Cohen Milstein
- Connolly Wells
- Cravath Swaine
- Eckert Seamans
- Faruqi & Faruqi
- Fine Kaplan
- Garwin Gerstein
- Hagens Berman
- Hangley Aronchick
- Harkins Cunningham
- Heim Payne
- Hilliard & Shadowen
- Kaplan Fox
- Kenny Nachwalter
- Kirkland & Ellis
- Lewis Brisbois
- Marcus & Shapira
- Mintz Levin
- Montgomery McCracken
- NastLaw
- Odom & Des Roches
- Radice Law Firm
- Robinson & Cole
- Roetzel & Andress
- Smith Segura
- Sperling & Slater
- Stevens & Lee
- Taus Cebulash
- Troutman Pepper
- Venable LLP
- Volpe Koenig
- White and Williams
- Willkie Farr
- WilmerHale
- Winchester Sellers
- Zelle LLP
Companies
- Cardinal Health Inc.
- Cephalon Inc.
- CVS Health Corp.
- Giant Eagle Inc.
- H.D. Smith LLC
- H‑E‑B LP
- J.M. Smith Corp.
- McKesson Corp.
- Mutual Drug
- Publix Super Markets Inc.
- Ranbaxy
- Rite Aid Corp.
- Rochester Drug Cooperative Inc.
- Safeway Inc.
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- The Harvard Drug Group LLC
- The Kroger Co.
Sectors & Industries:
-
April 20, 2015
Teva To Pay $512M To End Provigil Pay-For-Delay Dispute
Teva Pharmaceutical Industries Ltd. and subsidiaries Cephalon Inc. and Barr Pharmaceuticals Inc. have agreed to pay $512 million to settle with the direct purchasers in pay-for-delay litigation over Cephalon's narcolepsy drug Provigil, according to court documents filed Friday.
-
April 02, 2015
Aggrenox Doesn't Apply In Provigil Pay-For-Delay Suit: Teva
Teva Pharmaceutical Industries Ltd. on Thursday urged a Pennsylvania federal judge in a pay-for-delay suit over subsidiary Cephalon Inc.'s Provigil narcolepsy drug to ignore the plaintiffs' assertion that a decision in Aggrenox antitrust litigation means that the court should deny its motion to dismiss, saying they misread the opinion.
-
March 27, 2015
Provigil Pay-For-Delay Suit Survives Reconsideration Bid
A Pennsylvania federal judge on Friday declined to reconsider his ruling that a handful of pay-for-delay suits against drugmaker Cephalon Inc. over its Provigil narcolepsy drug meets the U.S. Supreme Court's Actavis standard allowing parties to sue drugmakers over settlements to delay the entry of generic drugs.
-
March 19, 2015
Provigil Buyers Drop Fight Over Teva Off-Books Deals
A Pennsylvania federal judge on Wednesday approved an agreement between direct buyers of Provigil and Teva Pharmaceutical Industries Ltd. to drop plaintiffs' calls for an escrow account for side settlements between the pharmaceutical company and potential class members, in the long-running antitrust suit over the drug.
-
March 11, 2015
Teva Fights Provigil Attys Over Shielding Settlement Fees
Teva Pharmaceutical Industries Ltd. on Wednesday in a Pennsylvania federal court slammed a bid by direct buyers of Provigil to set up an escrow account for portions of any side settlements between the drug giant and potential class members in an antitrust suit over the narcolepsy drug.
-
March 10, 2015
Provigil Attys Look To Shield Fees In Teva Settlements
Direct buyers of narcolepsy drug Provigil on Tuesday urged a Pennsylvania federal judge to order Teva Pharmaceutical Industries Ltd. to create an escrow account for portions of any side settlements between the drugmaker and potential class members in the antitrust case.
-
March 04, 2015
Provigil Buyers Say Teva Coercing Distributors To Pare Suit
Direct buyers of narcolepsy drug Provigil on Tuesday urged a Pennsylvania federal judge to block Teva Pharmaceutical Industries Ltd. from communicating with potential class members in the antitrust case, saying the drugmaker is trying to coerce distributors into accepting cheap settlements of their pay-for-delay claims.
-
June 23, 2014
Provigil Judge Nixes Conspiracy Claims In Antitrust Suit
A Pennsylvania federal judge ruled on Monday that Apotex Inc. and Provigil buyers could not prove that reverse payment patent settlements Cephalon Inc. inked with four generic-drug makers amounted to a conspiracy among the defendants to keep cheaper versions of the narcolepsy drug off the market.
-
January 23, 2014
Cephalon Says Patent Toss Doesn't Bar Pay-For-Delay Defense
Cephalon Inc. told a Pennsylvania federal judge Thursday that it should be allowed to defend a series of pay-for-delay deals it struck with generic-drug competitors over the narcolepsy drug Provigil during a potential trial on antitrust claims brought by several purchaser classes.
-
January 09, 2014
Inequitable Conduct Won't Undo Attorney-Client Privilege
The deceit Cephalon Inc. researcher and attorney allegedly used to obtain a patent for the drug Provigil didn't exempt communications between the drugmaker and its lawyers from attorney-client privilege, a Pennsylvania federal judge ruled Thursday, denying a motion in a pay-for-delay class action.
- ← Previous
- 1
- 2
- 3
- 4
- Next →